ISTH 2021 Congress
Venous Thromboembolism » Antiphospholipid Syndrome
Theme Navigation
- ISTH 2021 Congress
- Venous Thromboembolism
- Antiphospholipid Syndrome
- Venous Thromboembolism
-
Abstract Number: PB1057
A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter
-
Abstract Number: PB1055
A Novel ELISA Assay for the Detection of Anti-prothrombin Antibodies in APS Patients at High Risk of Thrombosis
-
Abstract Number: PB1068
A Prolonged Actived Partial Thromboplastin Time Revealing a Childhood Systemic Lupus erythematosus
-
Abstract Number: PB1054
Artificial Intelligence Classifies APS in Anticoagulated Patients Based on Thrombin Generation
-
Abstract Number: PB1064
Automated Methods for the Enhancement of Lupus Anticoagulant Mixing Study Sensitivities
-
Abstract Number: OC 44.1
Clinical Characteristics and Prognosis of Antiphospholipid Syndrome Patients Based on Cluster Analysis: A 10-year Cohort Study
-
Abstract Number: PB1051
Clinical Course of Thrombotic Antiphospholipid Syndrome with Positive IgA Anticardiolipin or IgA β2-glycoprotein I
-
Abstract Number: PB1063
Clinico-pathologic Characterization of Patients Tested for Antiphospholipid Syndrome at a Tertiary Care Hospital
-
Abstract Number: PB1053
Effect of Hydroxychloroquine on the Levels of Inflammatory Cytokines and Tissue Factor in Patients with Primary Antiphospholipid Syndrome
-
Abstract Number: PB1059
Evaluation of a Gene Signature Related to Thrombotic Manifestations in Antifospholipid Syndrome
-
Abstract Number: PB1066
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban at Lupus Anticoagulans Positive Patients
-
Abstract Number: OC 44.4
Origin of Antiphospholipid Antibodies in Autoimmunity and Viral Infection
-
Abstract Number: PB1061
Plasmocytoid Dendritic Cells Activity in Asymptomatic Antiphospholipid Carriers and in Primary and Secondary Antiphospholipid Syndrome with Thrombosis
-
Abstract Number: PB1060
Platelet Activity from Antiphospholipid Syndrome (APS) Patients is Enhanced: Possible Role of the ADP Signaling Pathway
-
Abstract Number: OC 44.2
Predictors of Lupus Anticoagulant Test Variability over Time and its Associations with Future Thrombotic Events: Results from the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)
-
Abstract Number: OC 44.3
Progression of Ischaemic and Haemorrhagic Brain Lesions on MRI in APS Patients on Antithrombotic Therapy
-
Abstract Number: PO164
Real World Experience Use of DOAC in APLS Patients